BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6976843)

  • 1. Prospects for the development of malaria vaccines.
    Wernsdorfer WH
    Bull World Health Organ; 1981; 59(3):335-41. PubMed ID: 6976843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
    Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of malaria vaccines: memorandum from a USAID/WHO meeting.
    Bull World Health Organ; 1983; 61(1):81-92. PubMed ID: 6340848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for vaccination against malaria in man.
    Corradetti A
    Bull World Health Organ; 1974; 50(3-4):287-91. PubMed ID: 4216411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine against human malaria--an utopia?
    Peltola H
    Ann Clin Res; 1982 Dec; 14(5-6):260-6. PubMed ID: 7171233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria vaccination with irradiated sporozoites: serological evaluation of the antigen and antibody responses.
    Bawden MP; Palmer TT; Leef MF; Beaudoin RL
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):205-9. PubMed ID: 120769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally acquired immunity to Plasmodium falciparum malaria in Africa.
    Hviid L
    Acta Trop; 2005 Sep; 95(3):270-5. PubMed ID: 16018958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic structure and related aspects of the biology of plasmodia: the present situation: Scientific Working Group on the Immunology of Malaria.
    Scientific Working Group on the Immunology of Malaria
    Bull World Health Organ; 1981; 59(3):371-81. PubMed ID: 7034986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey.
    Wijayalath WA; Cheesman S; Rajakaruna J; Handunnetti SM; Carter R; Pathirana PP
    Parasite Immunol; 2008; 30(11-12):630-6. PubMed ID: 19067844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on malaria vaccines.
    Desowitz RS; Miller LH
    Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
    Moorthy VS; Diggs C; Ferro S; Good MF; Herrera S; Hill AV; Imoukhuede EB; Kumar S; Loucq C; Marsh K; Ockenhouse CF; Richie TL; Sauerwein RW
    Vaccine; 2009 Sep; 27(42):5719-25. PubMed ID: 19654061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
    Stoute JA; Slaoui M; Heppner DG; Momin P; Kester KE; Desmons P; Wellde BT; Garçon N; Krzych U; Marchand M
    N Engl J Med; 1997 Jan; 336(2):86-91. PubMed ID: 8988885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.